PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,563 | +213.7% | 6,250 | +212.5% | 0.00% | – |
| Q2 2023 | $10,061 | -34.6% | 2,000 | -20.0% | 0.00% | – |
| Q1 2023 | $15,376 | +18.3% | 2,500 | +149.5% | 0.00% | – |
| Q4 2022 | $13,000 | +333.3% | 1,002 | +0.2% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 1,000 | -1.1% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 1,011 | -10.6% | 0.00% | – |
| Q1 2022 | $7,000 | -36.4% | 1,131 | -18.1% | 0.00% | – |
| Q4 2021 | $11,000 | -56.0% | 1,381 | -15.3% | 0.00% | – |
| Q3 2021 | $25,000 | -21.9% | 1,631 | -35.0% | 0.00% | – |
| Q2 2021 | $32,000 | +357.1% | 2,511 | +66.2% | 0.00% | – |
| Q1 2021 | $7,000 | +250.0% | 1,511 | +86.3% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 811 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 811 | +7272.7% | 0.00% | – |
| Q2 2020 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |